Aptamers as New Tools for Inhibiting Cytokine Activity Howard A. Young Laboratory of Experimental Immunology Cancer and Inflammation Program National Cancer.

Slides:



Advertisements
Similar presentations
Tina Stutzman Nick Swenson May 12, 2010
Advertisements

Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase CRAIG TUERK AND LARRY GOLD.
Aptamers in the Real World Development and Applications NeoVentures Biotechnology Inc. Aptamers Applied1.
Non Specific Binding (NSB) in Antigen-Antibody Assays Chem 395 Spring 2007 Instructor : Dr. James Rusling Presenter : Bhaskara V. Chikkaveeraiah.
Viral Detection By: Douglas Tran.  Past research  States Prion hypothesis and past research of no past viral genetic material detected  States the.
Functional RNA - Introduction Part 2
POSTER TEMPLATE BY: Developing Novel Supported Membrane Interfaces for SPR Study of Transmembrane Proteins Heather Ferguson*,
Creating enzymes not found in nature Burckhard Seelig University of Minnesota & Harvard Medical School.
Hybridization Diagnostic tools Nucleic acid Basics PCR Electrophoresis
Yolanda M. Fortenberry, Ph.D. Hematology 2014 Conference
Detection of Carcinoembryonic antigen with sandwich-biosensor Alexander Pak, Antonina Malozemova, Luiza Niyazmetova, Mukhtar Sadykov, Zeinaf Muradova Nazarbayev.
PNAS ∣ August 24, 2010 ∣ vol. 107 ∣ no. 34 ∣ 15039–15044
Nanoparticles and their medical applications
with an emphasis on DNA microarrays
Synthetic biology Genome engineering Chris Yellman, U. Texas CSSB.
The effect of TCDD on cytokine production during the progression of insulitis in NOD mice Tuan Pham Dr. Nancy Kerkvliet Environmental and Molecular Toxicology.
Construction, Transformation, and Prokaryote Expression of a Fused GFP and Mutant Human IL-13 Gene Sequence Lindsay Venditti, Department of Biological.
Biomolecules: Nucleic Acids and Proteins
Transfection. What is transfection? Broadly defined, transfection is the process of artificially introducing nucleic acids (DNA or RNA) into cells, utilizing.
Applications of Aptamers as Sensors
Biotechnology in Medicine Chapter 12.
Example RTK: EGF receptor
A carboxylated Zn-phthalocyanine inhibits the fibril formation of Alzheimer’s amyloid β peptide Atsushi Nagai Dept. Laboratory Medicine Shimane University.
Anti-mRNA Strategies What is the antisense oligonucleotides? - Synthetic genetic material. - Interacts with natural genetic material (DNA or RNA) prevent.
RNA-metabolite interactions (riboswitches). RNA aptamers RNA aptamers are structures that bind specifically to target ligands Many aptamers have been.
WANG HANLU Advance in research of aptamers and related drugs.
Discovering Macromolecular Interactions. An experimental strategy for identifying new molecular actors in a process candidate approach general screen.
Synthesis of pyrimidine bases
ProteoNova™ Inc. Overview © 2008 ProteoNova™, Inc.
Mark Fang Stanford iGEM 08-09

Northern blotting & mRNA detection by qPCR - part 2.
Newer method to sequence whole genomes –Uses allyl protecting group: Sequencing by Synthesis.
Analysis of protein-DNA interactions with tiling microarrays
1. Subash Chandra Bose Gopinath, Anal Bioanal Chem (2007) 387:171–182 Presented by: chang chu Guided by: Prof. Liu Prof. Jiang Methods developed for SELEX.
Motif Search and RNA Structure Prediction Lesson 9.
Microbial Genetics. DNA is the Genetic Material Griffiths Avery et al.
Vigdis Lauvrak Bio H2003 Phage display.
From: Duggan et.al. Nature Genetics 21:10-14, 1999 Microarray-Based Assays (The Basics) Each feature or “spot” represents a specific expressed gene (mRNA).
NCode TM miRNA Analysis Platform Identifies Differentially Expressed Novel miRNAs in Adenocarcinoma Using Clinical Human Samples Provided By BioServe.
1 From Bi 150 Lecture 0 October 4, 2012 An introduction to molecular biology... but you will learn the cell biology in this course.
What is phage display? An in vitro selection technique using a peptide or protein genetically fused to the coat protein of a bacteriophage.
GENISTEIN-MEDIATED PROTECTION AGAINST INTERLEUKIN-4-INDUCED INFLAMMATORY PATHWAYS IN HUMAN VASCULAR ENDOTHELIAL CELLS Yong Woo Lee 1, Bernhard Hennig 2,
Interferon-γ (IFNγ), a cytokine secreted by effector lymphocytes upon activation, is known to cause upregulation of MHC class I in tumor cells, which has.
Michael Spruyt, Frank Buquicchio, Leigh-Ann Ricks & Neil Goldstein
iGEM Meeting – 19/04/17: SELEX & Riboswitches
Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells  Rosalba Salcedo, Ken Wasserman,
Programmable Materials for Drug Delivery and Regenerative Medicine
InVITRO selection (SELEX)
Chemically Induced Hairpin Formation in DNA Monolayers
V. Protein Chips 1. What is Protein Chips 2. How to Make Protein Chips
A new nucleic acid–based agent inhibits cytotoxic T lymphocyte–mediated immune disorders  Chuang-Wei Wang, MS, Wen-Hung Chung, MD, PhD, Yi-Fang Cheng,
Ligand Docking to MHC Class I Molecules
Oligonucleotide aptamer-targeted immune modulation.
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
Volume 22, Issue 3, Pages (March 2015)
From selection hits to clinical leads: progress in aptamer discovery
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization  Abdullah Ozer, John M Pagano,
Kevin M. Marks, Michael Rosinov, Garry P. Nolan  Chemistry & Biology 
Wei-Yun Lai, Bo-Tsang Huang, Jen-Wei Wang, Pei-Ying Lin, Pan-Chyr Yang 
Volume 92, Issue 6, Pages (March 1998)
Coby B. Carlson, Momchilo Vuyisich, Barry D. Gooch, Peter A. Beal 
A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
Molecular Therapy - Nucleic Acids
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer  Jun Young Park, Ye Lim Cho, Ju Ri Chae, Sung Hwan Moon,
by Kevin J. Paavola, Harwin Sidik, J
Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression  Jun-Li Luo, Shin.
Presentation transcript:

Aptamers as New Tools for Inhibiting Cytokine Activity Howard A. Young Laboratory of Experimental Immunology Cancer and Inflammation Program National Cancer Institute at Frederick Frederick, MD

Collaboration with: Nucleic Acid Synthetic Biology Resarch Team Systems and structural Biology Center Yokohama Institute, RIKEN Ichiro Hirao Team Leader RIKEN Center for Life Science Technologies President & CEO TagCyx Biotechnologies

Aptamers (from the Latin aptus - fit, and Greek meros - part) are oligonucleic acid or peptide molecules that bind to a specific target molecule.

Nat Biotechnol.Nat Biotechnol May;31(5): doi: /nbt Epub 2013 Apr 7. Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Kimoto M Kimoto M 1, Yamashige R, Matsunaga K, Yokoyama S, Hirao I.Yamashige RMatsunaga KYokoyama SHirao I Abstract DNA aptamers produced with natural or modified natural nucleotides often lack the desired binding affinity and specificity to target proteins. Here we describe a method for selecting DNA aptamers containing the four natural nucleotides and an unnatural nucleotide with the hydrophobic base 7-(2-thienyl)imidazo[4,5-b]pyridine (Ds). We incorporated up to three Ds nucleotides in a random sequence library, which is expected to increase the chemical and structural diversity of the DNA molecules. Selection experiments against two human target proteins, vascular endothelial cell growth factor-165 (VEGF-165) and interferon-γ (IFN-γ), yielded DNA aptamers that bind with KD values of 0.65 pM and nM, respectively, affinities that are >100-fold improved over those of aptamers containing only natural bases. These results show that incorporation of unnatural bases can yield aptamers with greatly augmented affinities, suggesting the potential of genetic alphabet expansion as a powerful tool for creating highly functional nucleic acids.

Genetic alphabet expansion of the central dogma by unnatural base pairs DNA aptamers, PCR detection RNA labeling, functional RNAs Unnatural proteins Next-generation biotechnology by synthetic xenobiology In vivo systems Ds Px Diagnostic and therapeutic applications Nat. Methods, 3, 729 (2006). Nucleic Acids Res., 37, e14 (2009). Nucleic Acids Res., 40, 2793 (2012).

DNA aptamer selection for protein targets Selection PCR amplification DNA aptamer Conventional DNA library Conventional aptamer selection Selection PCR amplification DNA aptamer New DNA library with five different bases Unnatural base New methods using unnatural base pair systems High affinity ? In vitro selection (SELEX) A.D. Ellington & J.W. Szostak, Nature, 346, 818 (1990). C. Tuerk & L. Gold, Science, 249, 505 (1990). D.L. Robertson & G.F. Joyce, Nature, 344, 467 (1990).

Systematic Evolution of Ligands by Exponential Enrichment SELEX involving the Ds−Px pair DsPx Selection PCR amplification DNA aptamer Target protein Nature Biotechnol., 31, (2013). 2 ) Increase in structural diversity because of no pairing partner of Ds because of no pairing partner of Ds 1) Increase in hydrophobicity DNA aptamer Hydrophobic Ds Target protein Hydrophobic pocket

High affinity aptamer generation by an unnatural base pair system Selection PCRamplification Target protein Ds-aptamer : protein complex Ds-containing DNA library SELEX Ds-base New nucleic acid antibodies The binding abilities represented more than a 100-fold increase compared with those for conventional DNA aptamers. Nature Biotechnol., 31, (2013).

Anti-IFNγ DNA aptamer selection Ds T T C C 12 T A G G T T G G G G T G T A G G G C C GG A T C T A Ds T T T TA A 29 A Ds 40 G A ctcac Stem-1 Stem-2 GG >96% >99% <80% : DMS : DMS, protected by protein binding : KMnO 4 : KMnO 4, protected by protein binding : KMnO 4, enhanced by protein binding : MungBean nuclease, protected by protein binding Base conservation after the doped selection Chemical and enzymatic probing : MungBean nuclease Anti-IFNγ Ds x 3 (49-mer) Nature Biotechnol., 31, (2013).

Anti-IFNγ DNA aptamer selection Tm = 37.6 ˚C Tm = 33.1 ˚C Ds Anti-IFNγ Ds x 3 (49-mer) K D = nM 38 pM 38 pM Nature Biotechnol., 31, (2013) Response units (RU) Time (sec) IFNγ (nM) 1.25 A A A Anti-IFNγ A x 3 (49-mer) K D = 7.21 nM Time (sec) 600 Ramanathan, M. et al., Transplantation, 52, 612 (1994). Known anti-IFNγ DNA aptamer (26-mer) K D = 16.6 nM Time (sec) nM 20 nM 10 nM 5 nM 2.5 nM IFN-γ

Anti-IFNγ DNA aptamer selection Protein 20 nM Normalized Responses High selectivity of the anti-IFNγ aptamer (aptamer Ds x 3, 49-mer) VEGF 165 BSA VEGF 121 IFNγ EGF Thrombin Time (sec) Sensorgrams (SPR) for the binding of different proteins (20 nM) to 5′-biotinylated aptamer Ds x 3 (49-mer) in 1×PBS % NP40 Nature Biotechnol., 31, (2013).

Assay for Biological Activity Treat target cell (human breast tumor cell line) with IFN-  for 10 minutes Assay for phospho-STAT1 via flow cytometry

Aptamer effects on IFNγ induced pSTAT1 at 37˚C for 10 min 2 ng 10 ng 100 ng 38 pM IFNγ = 2 ng Aptameraddition Unpublished data 2 ng 10 ng 100 ng 16 nM Anal. Chem., 82, 1851 (2010).

Nuclease degradation and stabilization of aptamers 10 min 37˚CO/Nr.t.O/N37˚C 38 pM 10 min 37˚CO/Nr.t.O/N37˚C 5’ 3’ Unpublished data

Conclusions: 1. IFN-  aptamer interaction is extremely rapid 2. Aptamer blocks IFN-  interaction with cell surface receptor DNA-Aptamer Time Course and Effect of Wash out and Restimulation

Stabilization of DNA aptamers by attaching a mini-hairpin DNA sequence Ds (hr) In 96 % human serum Ds-DNA aptamer + Mini-hairpin DNA Unpublished data

Stability of the mini-hairpin DNAs against nucleases

Extraordinarily thermal stable mini-hairpin DNA (dGCGAAGC) Nucleic Acids Res., 17, 2223 (1989) and 22, 576 (1994). Tm = 76.5 ˚C

Aptamer (100 ng/ml) effects on IFNγ induced pSTAT1 at 37˚C, overnight Kd = 16 nM Unpublished data 200 ng/ml

Diagnostic and therapeutic applications of new DNA aptamers 20 Ds Unnatural-base DNA aptamers Mini-hairpin DNA High stable and high affinity DNA aptamers for imaging, diagnostics and therapeutics

Acknowledgements RIKEN Center for Life Science Technologies TagCyx Biotechnologies Dr. Ichiro Hirao NCI at Frederick Charlotte Hanson Michael Sanford